Barely Significant
← all excerpts

Quantifying <i>NPM1</i> MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line?

Hemasphere · 2024 · PMC10946283 · PMID 38501048

Europe PMCDOI
1
hedged sentence
0.1000
closest p · 2.0× alpha
0.1000
boldest claim

The sentences

showed a trendp = 0.10so close (0.05 < p ≤ 0.1)
In addition, compared to patients with low NPM1 MRD levels, patients with high NPM1 MRD levels also showed a trend for shorter OS ( p = 0.10; Figure 2C ), indicating that patients transplanted with higher NPM1 MRD may be harder to salvage after relapse following HSCT.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.